Variant report

Variant	esv3395665
Chromosome Location	chr12:50897710-50900258
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:50898502-50898861	HepG2	liver:	n/a	n/a
2	ATF2	chr12:50898393-50898873	GM12878	blood:	n/a	n/a
3	ATF3	chr12:50898422-50899357	A549	lung:	n/a	chr12:50898765-50898774 chr12:50898754-50898774 chr12:50898746-50898755
4	ATF3	chr12:50898522-50898910	H1-hESC	embryonic stem cell:	n/a	chr12:50898765-50898774 chr12:50898754-50898774 chr12:50898746-50898755
5	ATF3	chr12:50898599-50898883	HepG2	liver:	n/a	chr12:50898765-50898774 chr12:50898754-50898774 chr12:50898746-50898755
6	ATF3	chr12:50898534-50898922	K562	blood:	n/a	chr12:50898765-50898774 chr12:50898754-50898774 chr12:50898746-50898755
7	ATF3	chr12:50898568-50899076	GM12878	blood:	n/a	chr12:50898765-50898774 chr12:50898754-50898774 chr12:50898746-50898755
8	BACH1	chr12:50898514-50898755	H1-hESC	embryonic stem cell:	n/a	n/a
9	BCL3	chr12:50898362-50899368	A549	lung:	n/a	chr12:50898747-50898756 chr12:50898822-50898835 chr12:50898742-50898755
10	BCLAF1	chr12:50898500-50899128	GM12878	blood:	n/a	chr12:50898747-50898756 chr12:50898822-50898835 chr12:50898742-50898755
11	BCLAF1	chr12:50898443-50900078	GM12878	blood:	n/a	chr12:50898747-50898756 chr12:50898822-50898835 chr12:50898742-50898755
12	BHLHE40	chr12:50898492-50899334	K562	blood:	n/a	chr12:50898763-50898776 chr12:50898765-50898774 chr12:50898766-50898775 chr12:50898765-50898774 chr12:50898759-50898780 chr12:50898819-50898835 chr12:50898764-50898773
13	BHLHE40	chr12:50899566-50900046	GM12878	blood:	n/a	n/a
14	BHLHE40	chr12:50898463-50899167	HepG2	liver:	n/a	chr12:50898763-50898776 chr12:50898765-50898774 chr12:50898766-50898775 chr12:50898765-50898774 chr12:50898759-50898780 chr12:50898819-50898835 chr12:50898764-50898773
15	BHLHE40	chr12:50899844-50900041	K562	blood:	n/a	n/a
16	BHLHE40	chr12:50898480-50899225	GM12878	blood:	n/a	chr12:50898763-50898776 chr12:50898765-50898774 chr12:50898766-50898775 chr12:50898765-50898774 chr12:50898759-50898780 chr12:50898819-50898835 chr12:50898764-50898773
17	BRCA1	chr12:50898578-50898845	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr12:50899108-50899578	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr12:50898591-50898677	GM12878	blood:	n/a	n/a
20	BRCA1	chr12:50899967-50900325	Hela-S3	cervix:	n/a	n/a
21	CBX3	chr12:50898416-50899047	K562	blood:	n/a	n/a
22	CCNT2	chr12:50898585-50899213	K562	blood:	n/a	chr12:50898746-50898755
23	CEBPB	chr12:50898496-50899019	Hela-S3	cervix:	n/a	chr12:50898583-50898595
24	CEBPB	chr12:50898573-50898779	H1-hESC	embryonic stem cell:	n/a	chr12:50898583-50898595
25	CHD1	chr12:50898647-50900248	GM12878	blood:	n/a	n/a
26	CHD1	chr12:50898272-50900085	IMR90	lung:	n/a	n/a
27	CHD1	chr12:50898856-50898916	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD1	chr12:50899250-50899376	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr12:50898484-50898782	K562	blood:	n/a	n/a
30	CHD2	chr12:50898569-50898710	HepG2	liver:	n/a	n/a
31	CHD2	chr12:50899238-50899493	K562	blood:	n/a	n/a
32	CHD2	chr12:50898566-50898999	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD2	chr12:50899186-50899689	GM12878	blood:	n/a	n/a
34	CHD2	chr12:50898552-50898858	GM12878	blood:	n/a	n/a
35	CHD2	chr12:50898517-50899562	Hela-S3	cervix:	n/a	n/a
36	CREB1	chr12:50898477-50899012	H1-hESC	embryonic stem cell:	n/a	n/a
37	CREB1	chr12:50898534-50898907	A549	lung:	n/a	n/a
38	CTCF	chr12:50898328-50899074	HCT-116	colon:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
39	CTCF	chr12:50898528-50898830	SK-N-SH_RA	brain:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
40	CTCF	chr12:50898549-50898796	LNCaP	prostate:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
41	CTCF	chr12:50898968-50899146	LNCaP	prostate:	n/a	n/a
42	CTCF	chr12:50898600-50898750	GM12868	blood:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
43	CTCF	chr12:50898876-50899185	Fibrobl	skin:	n/a	n/a
44	CTCF	chr12:50898427-50898820	T-47D	breast:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
45	CTCF	chr12:50898535-50898812	GM10266	blood:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
46	CTCF	chr12:50898560-50898710	HCT-116	colon:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
47	CTCF	chr12:50898519-50898836	MCF-7	breast:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
48	CTCF	chr12:50898600-50898750	AG04449	skin:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
49	CTCF	chr12:50898640-50898790	GM12865	blood:	n/a	chr12:50898673-50898686 chr12:50898670-50898688 chr12:50898673-50898686 chr12:50898671-50898687 chr12:50898672-50898693
50	CTCF	chr12:50898820-50898970	WERI-Rb-1	eye:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:50898761-50898811	HUVEC	blood vessel:	n/a
2	chr12:50898249-50898299	CMK	blood:	n/a
3	chr12:50899425-50899475	HCT-116	colon:	n/a
4	chr12:50899548-50899598	SK-N-SH_RA	brain:	n/a
5	chr12:50898411-50898461	U87	brain:	n/a
6	chr12:50898763-50898813	HepG2	liver:	n/a
7	chr12:50898622-50898672	HCPEpiC	choroid plexus:	n/a
8	chr12:50898761-50898811	HRCEpiC	kidney:	n/a
9	chr12:50898751-50898801	HepG2	liver:	n/a
10	chr12:50899548-50899598	ECC-1	luminal epithelium:	n/a
11	chr12:50898249-50898299	HEEpiC	esophagus:	n/a
12	chr12:50898763-50898813	SK-N-SH_RA	brain:	n/a
13	chr12:50898946-50898996	MCF-7	breast:	n/a
14	chr12:50898684-50898734	HIPEpiC	eye:	n/a
15	chr12:50898763-50898813	HUVEC	blood vessel:	n/a
16	chr12:50899425-50899475	Hela-S3	cervix:	n/a
17	chr12:50898622-50898672	Hepatocyte	liver:	n/a
18	chr12:50898411-50898461	NT2-D1	testis:	n/a
19	chr12:50899018-50899068	Jurkat	blood:	n/a
20	chr12:50898761-50898811	T-47D	breast:	n/a
21	chr12:50898622-50898672	A549	lung:	n/a
22	chr12:50898744-50898794	ovcar-3	ovarian:	n/a
23	chr12:50898684-50898734	SK-N-SH_RA	brain:	n/a
24	chr12:50898249-50898299	HIPEpiC	eye:	n/a
25	chr12:50898483-50898533	HRE	kidney:	n/a
26	chr12:50898751-50898801	ProgFib	skin:	n/a
27	chr12:50899425-50899475	AG04450	lung:	fetal
28	chr12:50898763-50898813	AG10803	skin:	n/a
29	chr12:50898483-50898533	AoSMC	blood vessel:	n/a
30	chr12:50898684-50898734	U87	brain:	n/a
31	chr12:50898249-50898299	IMR90	lung:	fetal
32	chr12:50898763-50898813	Hepatocyte	liver:	n/a
33	chr12:50898761-50898811	AG04450	lung:	fetal
34	chr12:50898411-50898461	NH-A	brain:	n/a
35	chr12:50898684-50898734	HPAEpiC	pulmonary alveolar:	n/a
36	chr12:50898622-50898672	ECC-1	luminal epithelium:	n/a
37	chr12:50898483-50898533	HCPEpiC	choroid plexus:	n/a
38	chr12:50899425-50899475	BE2_C	brain:	n/a
39	chr12:50898483-50898533	SK-N-MC	brain:	n/a
40	chr12:50898684-50898734	A549	lung:	n/a
41	chr12:50899425-50899475	HRCEpiC	kidney:	n/a
42	chr12:50898763-50898813	HCT-116	colon:	n/a
43	chr12:50898483-50898533	GM12878	blood:	n/a
44	chr12:50898946-50898996	GM06990	blood:	n/a
45	chr12:50898622-50898672	NT2-D1	testis:	n/a
46	chr12:50898483-50898533	GM12891	blood:	n/a
47	chr12:50898763-50898813	ovcar-3	ovarian:	n/a
48	chr12:50898751-50898801	HEEpiC	esophagus:	n/a
49	chr12:50898411-50898461	HL-60	blood:	n/a
50	chr12:50898411-50898461	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:50899429..50901096-chr12:50905405..50907049,2	MCF-7	breast:
2	chr12:50794531..50796202-chr12:50898772..50900284,2	MCF-7	breast:
3	chr12:50897453..50902823-chr12:51156009..51160960,8	MCF-7	breast:
4	chr12:50899807..50901324-chr12:50901368..50903053,2	MCF-7	breast:
5	chr12:50899485..50901952-chr12:50925003..50926748,2	MCF-7	breast:
6	chr12:50897880..50899909-chr12:51417990..51420226,2	MCF-7	breast:
7	chr12:50897096..50898748-chr12:51035347..51039565,3	MCF-7	breast:
8	chr12:50899387..50901154-chr12:50914806..50917491,2	K562	blood:
9	chr12:50897008..50898547-chr12:50959691..50961906,2	MCF-7	breast:
10	chr12:50898995..50900548-chr12:50993141..50995760,2	MCF-7	breast:
11	chr12:50899874..50900487-chr12:51031196..51031899,2	MCF-7	breast:
12	chr12:50897525..50900115-chr12:51025935..51031272,7	MCF-7	breast:
13	chr12:50897670..50898564-chr12:51035467..51036002,2	K562	blood:

Variant related genes	Relation type
DIP2B	TF binding region
DIP2B	CpG island
ENSG00000110911	chromatin interactions
ENSG00000123268	chromatin interactions
ENSG00000207136	chromatin interactions
ENSG00000161813	chromatin interactions

Extended variants
information (count: 103 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:103 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35036752	chr12:50897739-50897740	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs566424299	chr12:50897760-50897761	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs532052047	chr12:50897773-50897774	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs567853669	chr12:50897777-50897778	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs563656066	chr12:50897788-50897789	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs531054733	chr12:50897818-50897819	Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs561314363	chr12:50897882-50897883	Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs373157391	chr12:50897898-50897899	Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs28479152	chr12:50897926-50897927	Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs11302728	chr12:50897963-50897964	Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs398019515	chr12:50897978-50897979	Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs530063585	chr12:50897999-50898000	Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs568187252	chr12:50898006-50898007	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs540689004	chr12:50898014-50898015	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs536707928	chr12:50898028-50898029	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs553230069	chr12:50898029-50898030	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs113457700	chr12:50898042-50898043	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs538672898	chr12:50898043-50898044	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs558808577	chr12:50898045-50898046	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs370219247	chr12:50898089-50898090	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs575499247	chr12:50898101-50898102	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs11169465	chr12:50898110-50898111	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs74348131	chr12:50898126-50898127	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs574945251	chr12:50898181-50898182	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs142204046	chr12:50898190-50898191	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs564167303	chr12:50898193-50898194	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs192489371	chr12:50898211-50898212	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs532111570	chr12:50898224-50898225	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs183782675	chr12:50898229-50898230	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs562485915	chr12:50898255-50898256	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs531609719	chr12:50898280-50898281	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs11169466	chr12:50898296-50898297	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs568234030	chr12:50898361-50898362	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs377653745	chr12:50898420-50898421	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs147855330	chr12:50898433-50898434	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs79564340	chr12:50898435-50898436	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs566884841	chr12:50898448-50898449	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs377723986	chr12:50898483-50898484	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs546581591	chr12:50898520-50898521	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs558501302	chr12:50898529-50898530	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs79684541	chr12:50898568-50898569	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs538107603	chr12:50898722-50898723	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs61927768	chr12:50898728-50898729	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	mRNA abundance
44	rs370159733	chr12:50898732-50898733	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs7975780	chr12:50898754-50898755	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs368648487	chr12:50898759-50898760	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs540498691	chr12:50898769-50898770	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs560180152	chr12:50898774-50898775	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs372915240	chr12:50898778-50898779	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs576980972	chr12:50898783-50898784	Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Follicular lymphoma	20505157	CNVD
Hepatocellular carcinoma	16750200	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	17661082	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
Cancer	17160897	CNVD
Breast cancer	21858162	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:351 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:50897600-50898000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
2	chr12:50897800-50898000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr12:50898000-50898200	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr12:50898000-50898200	Enhancers	Primary T helper naive cells from peripheral blood	blood
5	chr12:50898000-50898200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr12:50898000-50898200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr12:50898000-50898200	Enhancers	Rectal Mucosa Donor 29	rectum
8	chr12:50898000-50898200	Enhancers	Skeletal Muscle Female	skeletal muscle
9	chr12:50898000-50898200	Enhancers	Stomach Smooth Muscle	stomach
10	chr12:50898000-50898200	Enhancers	A549	lung
11	chr12:50898000-50898200	Enhancers	Dnd41	blood
12	chr12:50898000-50898200	Enhancers	NHEK	skin
13	chr12:50898000-50898600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr12:50898200-50898400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr12:50898200-50898400	Enhancers	Primary B cells from peripheral blood	blood
16	chr12:50898200-50898400	Enhancers	Primary T cells fromperipheralblood	blood
17	chr12:50898200-50898400	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr12:50898200-50898400	Enhancers	Primary T helper cells PMA-I stimulated	--
19	chr12:50898200-50898400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
20	chr12:50898200-50898400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
21	chr12:50898200-50898400	Enhancers	Primary T killer memory cells from peripheral blood	blood
22	chr12:50898200-50898400	Enhancers	Cortex derived primary cultured neurospheres	brain
23	chr12:50898200-50898400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
24	chr12:50898200-50898400	Enhancers	Adipose Nuclei	Adipose
25	chr12:50898200-50898400	Enhancers	Brain Cingulate Gyrus	brain
26	chr12:50898200-50898400	Enhancers	Brain Hippocampus Middle	brain
27	chr12:50898200-50898400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
28	chr12:50898200-50898400	Enhancers	Fetal Muscle Leg	muscle
29	chr12:50898200-50898400	Enhancers	Fetal Thymus	thymus
30	chr12:50898200-50898400	Enhancers	Pancreas	Pancrea
31	chr12:50898200-50898400	Enhancers	Skeletal Muscle Male	skeletal muscle
32	chr12:50898200-50898400	Flanking Active TSS	HepG2	liver
33	chr12:50898200-50898600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
34	chr12:50898200-50898600	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
35	chr12:50898200-50898600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr12:50898200-50898600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr12:50898200-50898600	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
38	chr12:50898200-50898600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
39	chr12:50898200-50898600	Flanking Active TSS	Stomach Smooth Muscle	stomach
40	chr12:50898200-50898600	Flanking Active TSS	A549	lung
41	chr12:50898200-50898600	Flanking Active TSS	Dnd41	blood
42	chr12:50898200-50898600	Flanking Active TSS	NHEK	skin
43	chr12:50898200-50898800	Enhancers	Primary monocytes fromperipheralblood	blood
44	chr12:50898200-50898800	Enhancers	Primary neutrophils fromperipheralblood	blood
45	chr12:50898200-50899000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr12:50898200-50899000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr12:50898200-50899000	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr12:50898200-50899400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr12:50898200-50899400	Active TSS	Primary hematopoietic stem cells	blood
50	chr12:50898200-50899400	Active TSS	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links